Biblio Discovery — Demo Discovery Service

14 results for "Travis T. Sims"

Showing 1–14 · 0.55 seconds · RSS

  1. Journal Article Full text

    The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer

    Travis T. Sims; Lauren E. Colbert; Ann H. Klopp

    Journal of Immunotherapy and Precision Oncology, Pp 72-78 (2021) · 2021 · English · DOAJ Scopus

    The microbiome, which refers to the microbiota within a host and their collective genomes, has recently been demonstrated to play a critical role in cancer progression, metastasis, and therapeutic response. The microbiome is known to affect host immunity, but its influence on human papilloma virus…

  2. Journal Article

    Complete response to trastuzumab-deruxtecan (Enhertu, T-DXd) in HER2-positive stage IVB uterine carcinosarcoma

    Michael Kim; Amma Asare; Jamie L. Dockery et al.

    Gynecologic Oncology Reports, Vol. 60 · 2025 · English · DOAJ Scopus

    Objectives: To report a case of complete response to trastuzumab-deruxtecan (T-DXd) in a patient with HER2-positive stage IVB uterine carcinosarcoma, and to contextualize this within evolving therapy for HER2-positive gynecologic malignancies. Methods: We present the clinical course of a…

  3. Journal Article

    Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive Chemoradiation

    Travis T. Sims; Kyoko Yoshida-Court; Molly B. El Alam et al.

    JCO Global Oncology, Iss 11 (2025) · 2025 · English · DOAJ Scopus

    PURPOSECervical cancer remains a significant public health concern globally and particularly in sub-Saharan Africa, where high rates of HIV infection exacerbate cervical cancer incidence. Understanding the cervical microbiome and its role in cancer progression is essential, especially in regions…

  4. Journal Article Full text

    Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer

    Kyoko Yoshida-Court; Tatiana V. Karpinets; Aparna Mitra et al.

    PLOS ONE, Vol. 19 No. 11 · 2024 · English · PLOS Scopus

    [This corrects the article DOI: 10.1371/journal.pone.0279590.].

    Also available at: DOAJ

  5. Journal Article Full text

    Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer

    Kyoko Yoshida-Court; Tatiana V. Karpinets; Aparna Mitra et al.

    PLOS ONE, Vol. 18 No. 1 · 2023 · English · PLOS Scopus

    We evaluated the association of disease outcome with T cell immune-related characteristics and T cell receptor (TCR) repertoire in malignant ascites from patients with high-grade epithelial ovarian cancer. Ascitic fluid samples were collected from 47 high-grade epithelial ovarian cancer patients…

    Also available at: DOAJ

  6. Journal Article Full text

    A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

    Molly B. El Alam; Travis T. Sims; Ramez Kouzy et al.

    PLOS ONE, Vol. 16 No. 3 · 2021 · English · PLOS Scopus

    Background: A diverse and abundant gut microbiome can improve cancer patients’ treatment response; however, the effect of pelvic chemoradiotherapy (CRT) on gut diversity and composition is unclear. The purpose of this prospective study was to identify changes in the diversity and composition of the…

    Also available at: DOAJ

  7. Journal Article

    Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure

    Tatiana V. Karpinets; Xiaogang Wu; Travis Solley et al.

    BMC Cancer, Vol. 22 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Gut microbiome community composition differs between cervical cancer (CC) patients and healthy controls, and increased gut diversity is associated with improved outcomes after treatment. We proposed that functions of specific microbial species adjoining the mucus layer may…

  8. Journal Article

    Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

    Travis T. Sims; Molly B. El Alam; Tatiana V. Karpinets et al.

    Communications Biology, Vol. 4 No. 1 · 2021 · English · DOAJ Scopus

    Travis Sims and Molly El Alam et al. show that diversity of gut microbiota is associated with a favorable response to chemoradiation for cervical cancer and use flow cytometry to show that patients with high microbiome diversity had increased tumor infiltration of CD4+ lymphocytes as well as…

  9. Journal Article

    Germline variants in cancer susceptibility genes among patients with mucosal melanoma

    Afsaneh Amouzegar; Xiaogang Wu; James P. Long et al.

    npj Genomic Medicine, Vol. 11 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Mucosal melanoma (MM) is a rare and aggressive melanoma subtype with poor outcomes and poorly understood risk factors, including the contribution of germline pathogenic variants (PVs). In this study, 346 MM patients treated at MD Anderson Cancer Center underwent germline sequencing of 322…

  10. Journal Article Full text

    Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

    Lauren Elizabeth Colbert; Molly Blue El Alam; Rui Wang et al.

    Cancer Cell · 2023 · English · OpenAlex Scopus

    Tumor microbiota can produce active metabolites that affect cancer and immune cell signaling, metabolism, and proliferation. Here, we explore tumor and gut microbiome features that affect chemoradiation response in patients with cervical cancer using a combined approach of deep microbiome…